Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 29, 2025
Incidence, microbiology, and mortality of ventilation-associated pneumonia in a large Italian cohort of critically ill patients: results from the PROSAFE projectMarta Colaneri, Giorgia Montrucchio, Giovanni Scaglione, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 20, 2026
Andes virus-associated cardiopulmonary syndrome: diagnostic approaches, clinical management, and evidence gaps-a scoping reviewFederico Fama, Francesco Molà, Alberto Rizzo, et al.Antibiotics (Basel, Switzerland)|January 25, 2025
Vascular Access Device Infections: Current Management Practices and the Role of Multidisciplinary Teams at a Large Hospital in Northern ItalyMarta Colaneri, Lucia Galli, Martina Offer, et al.Infectious Diseases and Therapy|April 21, 2024
Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation StudyMarta Colaneri, Camilla Genovese, Federico Fassio, et al.Microorganisms|August 29, 2024
Epidemiology and Clinical Insights of Catheter-Related Candidemia in Non-ICU Patients with Vascular Access DevicesGiovanni Scaglione, Marta Colaneri, Martina Offer, et al.Biomedicines|August 26, 2022
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort StudySimona Biscarini, Simone Villa, Camilla Genovese, et al.American Journal of Infection Control|June 8, 2025
The CONSIDER study: Assessing the risk of catheter-associated bloodstream infections beyond the intensive care settingFabio Borgonovo, Marta Colaneri, Federico Fassio, et al.Biomedicines|June 28, 2023
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised PatientsAndrea Lombardi, Giulia Viero, Simone Villa, et al.Antimicrobial Resistance and Infection Control|August 29, 2022
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centresAgnese Comelli, Camilla Genovese, Andrea Lombardi, et al.Infection Prevention in Practice|December 18, 2024
Use of ICD-9-CM coding for identifying antibiotic prescriptions during hospitalization: a Delphi consensus modelAgnese Comelli, Camilla Genovese, Giulia Renisi, et al.Pageof 2